Member access

4-Traders Homepage  >  Shares  >  Euronext Bruxelles  >  UCB    UCB   BE0003739530

UCB (UCB)

290
Real-time Quote. Real-time TRADEGATE AG - 10/24 10:01:45 pm
65.7850 EUR   +0.27%
3d ago EXCLUSIVE- ADVENT, AVISTA NEAR DEAL : sources
4d agoUCB SA : quaterly earnings release
09/26 UCB : Acquisition of own shares
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Bruxelles
10/20/2014 10/21/2014 10/22/2014 10/23/2014 10/24/2014 Date
62.6(c) 63.88(c) 65.76(c) 66.38(c) 65.61(c) Last
419 312 346 111 371 071 287 595 356 256 Volume
-2.32% +2.04% +2.94% +0.94% -1.16% Change
More quotes
Company
UCB SA is a biopharmaceutical company that engages in the research, development and commercialization of innovative drugs in the fields of central nervous system and immunology disorders.The company focuses on the development of innovative medicines.It sells bio-pharmaceutical products for treating... 
Sector
Pharmaceuticals
Calendar
10/24Earnings Release
Surperformance© rating of UCB
Trading Rating : Investor Rating :
More about the company
Chart UCB
Duration : Period :
UCB Technical Analysis Chart | UCB | BE0003739530 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 3 557 M
EBIT 2014 517 M
Net income 2014 254 M
Debt 2014 1 483 M
Yield 2014 1,62%
Sales 2015 3 821 M
EBIT 2015 653 M
Net income 2015 381 M
Debt 2015 1 337 M
Yield 2015 1,86%
PER 2014 49,19
PER 2015 32,54
EV / Sales 2014 4,01x
EV / Sales 2015 3,69x
Capitalization 12 762 M
More Financials
Latest news on UCB
3d ago EXCLUSIVE- ADVENT, AVISTA NEAR DEAL : sources
4d agoUCB SA : quaterly earnings release
10/08 UCB : Georgia Bio and UCB to Host Parkinson's Gala Benefitting the National Park..
09/26 UCB : Acquisition of own shares
09/24 UCB : Patent Application Titled "Systems and Methods for Administering Medicatio..
09/23 Pending 'inversions' that new U.S. Treasury rules may hit
09/17 UCB : Patent Issued for Method for Producing Protein
09/11 Eastman Chemical to buy Taminco for $1.8 bln
09/10 UCB : Patent Application Titled "Pharmaceutical Composition Comprising Rotigotin..
08/05 EXCLUSIVE : Belgium's UCB explores sale of generics unit Kremers Urban - sources
08/01 UCB : Expands Access to Clinical Study Data (Transparency and Sharing)
07/28 Pfizer's need for deal looms larger with earnings report
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF